Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 624185, 7 pages
http://dx.doi.org/10.1155/2014/624185
Clinical Study

Sentinel Lymph Node Biopsy Should Be Included with the Initial Surgery for High-Risk Ductal Carcinoma-In-Situ

Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433

Received 23 April 2014; Revised 30 August 2014; Accepted 2 September 2014; Published 29 October 2014

Academic Editor: Qiuyin Cai

Copyright © 2014 Ern Yu Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Kelly, J. A. Kim, R. Patrick, S. Grundfest, and J. P. Crowe, “Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ,” The American Journal of Surgery, vol. 186, no. 4, pp. 368–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Intra, N. Rotmensz, P. Veronesi et al., “Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years,” Annals of Surgery, vol. 247, no. 2, pp. 315–319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Virnig, T. M. Tuttle, T. Shamliyan, and R. L. Kane, “Ductal carcinoma in Situ of the breast: a systematic review of incidence, treatment, and outcomes,” Journal of the National Cancer Institute, vol. 102, no. 3, pp. 170–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Katz, I. Gage, S. Evans et al., “Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer,” The American Journal of Surgery, vol. 191, no. 6, pp. 761–766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Sakr, M. Antoine, E. Barranger et al., “Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma,” Breast Journal, vol. 14, no. 1, pp. 55–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. E. Cox, K. Nguyen, R. J. Gray et al., “Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?” American Surgeon, vol. 67, no. 6, pp. 513–519, 2001. View at Google Scholar · View at Scopus
  7. S. Pendas, E. Dauway, R. Giuliano, N. Ku, C. E. Cox, and D. S. Reintgen, “Sentinel node biopsy in ductal carcinoma in situ patients,” Annals of Surgical Oncology, vol. 7, no. 1, pp. 15–20, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Jeevan, D. A. Cromwell, M. Trivella et al., “Reoperation rates after breast conserving surgery for breast cancer among women in England: Retrospective study of hospital episode statistics,” The British Medical Journal, vol. 345, no. 7869, Article ID e4505, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. E. Mansel, L. Fallowfield, M. Kissin et al., “Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial,” Journal of the National Cancer Institute, vol. 98, no. 9, pp. 599–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Silverstein, J. R. Waisman, P. Gamagami et al., “Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice,” Cancer, vol. 66, pp. 102–108, 1990. View at Google Scholar
  11. B. Fisher, J. Dignam, N. Wolmark et al., “Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B- 17,” Journal of Clinical Oncology, vol. 16, no. 2, pp. 441–452, 1998. View at Google Scholar · View at Scopus
  12. C. D. Murphy, J. L. Jones, S. H. Javid et al., “Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?” The American Journal of Surgery, vol. 196, no. 4, pp. 566–568, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Klauber-DeMore, L. K. Tan, L. Liberman et al., “Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?” Annals of Surgical Oncology, vol. 7, no. 9, pp. 636–642, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Wilkie, L. White, E. Dupont, A. Cantor, and C. E. Cox, “An update of sentinel lymph node mapping in patients with ductal carcinoma in situ,” The American Journal of Surgery, vol. 190, no. 4, pp. 563–566, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Huo, N. Sneige, K. K. Hunt, C. T. Albarracin, A. Lopez, and E. Resetkova, “Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ,” Cancer, vol. 107, no. 8, pp. 1760–1768, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. H. Lee, D. Carter, L. E. Philpotts et al., “Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?” Radiology, vol. 217, no. 2, pp. 466–470, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Pandelidis, D. Heilman, D. Jones, K. Stough, J. Trapeni, and Y. Suliman, “Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions,” Annals of Surgical Oncology, vol. 10, no. 1, pp. 43–47, 2003. View at Google Scholar · View at Scopus
  18. M. Y. Chan and S. Lim, “Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy,” Asian Journal of Surgery, vol. 33, no. 2, pp. 76–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Goyal, A. Douglas-Jones, I. Monypenny, H. Sweetland, G. Stevens, and R. E. Mansel, “Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases,” Breast Cancer Research and Treatment, vol. 98, no. 3, pp. 311–314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. F. Dillon, E. W. McDermott, C. M. Quinn, A. O'Doherty, N. O'Higgins, and A. D. K. Hill, “Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only,” Journal of Surgical Oncology, vol. 93, no. 7, pp. 559–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Y. Park, H. M. Gweon, E. J. Son, M. Yoo, J.-A. Kim, and J. H. Youk, “Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer,” European Journal of Radiology, vol. 83, no. 4, pp. 654–659, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. E. Brennan, R. M. Turner, S. Ciatto et al., “Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer,” Radiology, vol. 260, no. 1, pp. 119–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Meijnen, H. S. A. Oldenburg, C. E. Loo, O. E. Nieweg, J. L. Peterse, and E. J. T. Rutgers, “Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy,” British Journal of Surgery, vol. 94, no. 8, pp. 952–956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Ciatto, N. Houssami, D. Ambrogetti et al., “Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies,” Breast Cancer Research and Treatment, vol. 101, no. 3, pp. 291–297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. T. W. F. Yen, K. K. Hunt, M. I. Ross et al., “Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ,” Journal of the American College of Surgeons, vol. 200, no. 4, pp. 516–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. L. Page, W. D. Dupont, L. W. Rogers, and M. Landenberger, “Intraductal carcinoma of the breast: follow-up after biopsy only,” Cancer, vol. 49, no. 4, pp. 751–758, 1982. View at Google Scholar · View at Scopus
  27. L. C. Collins, R. M. Tamimi, H. J. Baer, J. L. Connolly, G. A. Colditz, and S. J. Schnitt, “Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the nurses' health study,” Cancer, vol. 103, no. 9, pp. 1778–1784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. P. D. J. Hardman, A. Worth, and U. Lee, “The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern,” Canadian Journal of Surgery, vol. 32, no. 1, pp. 56–60, 1989. View at Google Scholar · View at Scopus
  29. J. C. C. Tan, D. R. McCready, A. M. Easson, and W. L. Leong, “Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy,” Annals of Surgical Oncology, vol. 14, no. 2, pp. 638–645, 2007. View at Publisher · View at Google Scholar · View at Scopus